SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe who wrote (3637)1/13/2000 7:03:00 PM
From: BostonView   of 4140
 
>>``Obviously, this was life and death for Sunrise, and they got life,' said Kenneth Goldman, an analyst at Lehman Brothers.``This is a gigantic market.'<<

>>If the FDA follows the panel's recommendation and approves the device, Sunrise will have access to a market of more than 30 million farsighted patients, said Goldman.

Russell Trenary, Sunrise's chief executive, said the company would be ready to begin shipping the lasers the moment the FDA approves the device. ``We're highly focused on the fastest growing opportunity in ophthalmology,' Trenary said. <<

quote.bloomberg.com

BV
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext